|
|
 Previous Article | Table of Contents | Next Article 
Blood, Vol. 95 No. 11 (June 1), 2000:
pp. 3341-3348
Identification and characterization of a new human ETS-family
transcription factor, TEL2, that is expressed in hematopoietic
tissues and can associate with TEL1/ETV6
Mark D. Potter,
Arjan Buijs,
Brent Kreider,
Luc van Rompaey, and
Gerard C. Grosveld
From the Department of Genetics, St Jude's Children Research
Hospital, Memphis, TN; and Human Genome Sciences, Inc, Rockville, MD.
The ETS family of proteins is a large group of transcription factors
implicated in many aspects of normal hematopoietic development, as well
as oncogenesis. For example, the TEL1/ETV6 (TEL1) gene is
required for normal yolk sac angiogenesis, adult bone marrow hematopoiesis, and is rearranged or deleted in numerous leukemias. This
report describes the cloning and characterization of a novel ETS gene that is highly related to TEL1 and is
therefore called TEL2. The TEL2 gene consists of 8 exons spanning approximately 21 kilobases (kb) in human chromosome
6p21. Unlike the ubiquitously expressed TEL1 gene, however,
TEL2 appears to be expressed predominantly in hematopoietic
tissues. Antibodies raised against the C-terminus of the TEL2 protein
were used to show that TEL2 localizes to the nucleus. All ETS
proteins can bind DNA via the highly conserved ETS domain, which
recognizes a purine-rich DNA sequence with a GGAA core motif. DNA
binding assays show that TEL2 can bind the same consensus DNA binding
sequence recognized by TEL1/ETV6. Additionally, the TEL2
protein is capable of associating with itself and with TEL1 in
doubly transfected Hela cells, and this interaction is mediated through
the pointed (PNT) domain of TEL1. The striking similarities of
TEL2 to the oncogenic TEL1, its
expression in hematopoietic tissues, and its ability to associate with
TEL1 suggest that TEL2 may be an important hematopoietic
regulatory protein.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
M. G. Roukens, M. Alloul-Ramdhani, S. Moghadasi, M. Op den Brouw, and D. A. Baker
Downregulation of Vertebrate Tel (ETV6) and Drosophila Yan Is Facilitated by an Evolutionarily Conserved Mechanism of F-Box-Mediated Ubiquitination
Mol. Cell. Biol.,
July 1, 2008;
28(13):
4394 - 4406.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. Carella, M. Potter, J. Bonten, J. E. Rehg, G. Neale, and G. C. Grosveld
The ETS factor TEL2 is a hematopoietic oncoprotein
Blood,
February 1, 2006;
107(3):
1124 - 1132.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. Kawagoe and G. C. Grosveld
MN1-TEL myeloid oncoprotein expressed in multipotent progenitors perturbs both myeloid and lymphoid growth and causes T-lymphoid tumors in mice
Blood,
December 15, 2005;
106(13):
4278 - 4286.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
F. Nakamura, Y. Nakamura, K. Maki, Y. Sato, and K. Mitani
Cloning and Characterization of the Novel Chimeric Gene TEL/PTPRR in Acute Myelogenous Leukemia with inv(12)(p13q13)
Cancer Res.,
August 1, 2005;
65(15):
6612 - 6621.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
W. A.G. Stams, M. L. den Boer, H. B. Beverloo, J. P.P. Meijerink, E. R. van Wering, G. E. Janka-Schaub, and R. Pieters
Expression Levels of TEL, AML1, and the Fusion Products TEL-AML1 and AML1-TEL versus Drug Sensitivity and Clinical Outcome in t(12;21)-Positive Pediatric Acute Lymphoblastic Leukemia
Clin. Cancer Res.,
April 15, 2005;
11(8):
2974 - 2980.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Cardone, A. Kandilci, C. Carella, J. A. Nilsson, J. A. Brennan, S. Sirma, U. Ozbek, K. Boyd, J. L. Cleveland, and G. C. Grosveld
The Novel ETS Factor TEL2 Cooperates with Myc in B Lymphomagenesis
Mol. Cell. Biol.,
March 15, 2005;
25(6):
2395 - 2405.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. Kawagoe, M. Potter, J. Ellis, and G. C. Grosveld
TEL2, an ETS Factor Expressed in Human Leukemia, Regulates Monocytic Differentiation of U937 Cells and Blocks the Inhibitory Effect of TEL1 on Ras-Induced Cellular Transformation
Cancer Res.,
September 1, 2004;
64(17):
6091 - 6100.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. Maki, H. Arai, K. Waga, K. Sasaki, F. Nakamura, Y. Imai, M. Kurokawa, H. Hirai, and K. Mitani
Leukemia-Related Transcription Factor TEL Is Negatively Regulated through Extracellular Signal-Regulated Kinase-Induced Phosphorylation
Mol. Cell. Biol.,
April 15, 2004;
24(8):
3227 - 3237.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. J. Irvin, L. D. Wood, L. Wang, R. Fenrick, C. G. Sansam, G. Packham, M. Kinch, E. Yang, and S. W. Hiebert
TEL, a Putative Tumor Suppressor, Induces Apoptosis and Represses Transcription of Bcl-XL
J. Biol. Chem.,
November 21, 2003;
278(47):
46378 - 46386.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. Boccuni, D. MacGrogan, J. M. Scandura, and S. D. Nimer
The Human L(3)MBT Polycomb Group Protein Is a Transcriptional Repressor and Interacts Physically and Functionally with TEL (ETV6)
J. Biol. Chem.,
April 18, 2003;
278(17):
15412 - 15420.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. D. Wood, B. J. Irvin, G. Nucifora, K. S. Luce, and S. W. Hiebert
Small ubiquitin-like modifier conjugation regulates nuclear export of TEL, a putative tumor suppressor
PNAS,
March 18, 2003;
100(6):
3257 - 3262.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. L. Tootle, P. S. Lee, and I. Rebay
CRM1-mediated nuclear export and regulated activity of the Receptor Tyrosine Kinase antagonist YAN require specific interactions with MAE
Development,
March 1, 2003;
130(5):
845 - 857.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. Ramachander, C. A. Kim, M. L. Phillips, C. D. Mackereth, C. D. Thanos, L. P. McIntosh, and J. U. Bowie
Oligomerization-dependent Association of the SAM Domains from Schizosaccharomyces pombe Byr2 and Ste4
J. Biol. Chem.,
October 11, 2002;
277(42):
39585 - 39593.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. Wasylyk, S. E. Schlumberger, P. Criqui-Filipe, and B. Wasylyk
Sp100 Interacts with ETS-1 and Stimulates Its Transcriptional Activity
Mol. Cell. Biol.,
April 15, 2002;
22(8):
2687 - 2702.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. J. Seidel and B. J. Graves
An ERK2 docking site in the Pointed domain distinguishes a subset of ETS transcription factors
Genes & Dev.,
January 1, 2002;
16(1):
127 - 137.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
X. Gu, B.-H. Shin, Y. Akbarali, A. Weiss, J. Boltax, P. Oettgen, and T. A. Libermann
Tel-2 Is a Novel Transcriptional Repressor Related to the Ets Factor Tel/ETV-6
J. Biol. Chem.,
March 16, 2001;
276(12):
9421 - 9436.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
